Massachusetts legislation · 194th General Court
Massachusetts H5013: An Act to establish a celiac disease screening pilot program
Status: In committee, July 27, 2026
What the bill says
From the introduced text, January 7, 2026:
(a) For the purpose of this act, the following terms shall, unless the context clearly requires otherwise, have the following meanings: “Celiac disease”, an autoimmune condition where the immune system reacts to gluten. 'Commissioner'', the commissioner of public health. “Department”, the department of public health. “Health care provider”, any: (i) doctor of medicine, registered nurse or registered pharmacist, licensed pursuant to chapter 112 of the General Laws; (ii) intern, resident, fellow or medical officer licensed pursuant to section 9 of said chapter 112; (iii) hospital, clinic or nursing home licensed pursuant to chapter 111 of the General Laws and its agents and employees; (iv) public hospital and its agents and employees; or (v) integrated health care delivery network comprising 1 or more hospitals licensed under section 51 of said chapter 111 and affiliated providers operating under common ownership or control. (b) The department shall establish a 3-year pilot program to evaluate the potential of including the screening of celiac disease by health care providers when conducting screenings of cholesterol and lipids for 12 year olds in the commonwealth. (c) The program shall: (i) improve early detection of celiac disease in children; (ii) help reduce long-term health consequences; and (iii) support families navigating a diagnosis of celiac disease. (d) Health care providers within the commonwealth shall be allowed to participate in …
Sponsors
- Michelle Badger (D) · primary sponsor
- Hannah Bowen (D, 6th Essex)
- Danillo Sena (D)
- Hadley Luddy (D)
- Adrian Madaro (D)
- Jack Lewis (D, 7th Middlesex)
- Steven Ouellette (D)
- Kathleen LaNatra (D, 12th Plymouth)
- Natalie Higgins (D, 4th Worcester)
- Rob Consalvo (D, 14th Suffolk)
- Samantha Montaño (D)
- Lindsay Sabadosa (D, 1st Hampshire)
Latest actions
- : Committee recommended bill ought to pass and referred to the committee on House Ways and Means
- : Reporting date extended to Thursday, December 31, 2026
- : Reported favorably by committee and referred to the committee on Health Care Financing
- : Hearing rescheduled to 03/23/2026 from 10:00 AM-11:15 AM in B-1 and Virtual<br> <span style="color: blue; font-style: italic;">Hearing updated to New End Time</span>
- : Hearing rescheduled to 03/23/2026 from 10:00 AM-11:15 PM in B-1 and Virtual<br> <span style="color: blue; font-style: italic;">Hearing updated to New End Time</span>
- : Hearing scheduled for 03/23/2026 from 10:00 AM-01:00 PM in B-1
- : Senate concurred
- : Reported, referred to the committee on Joint Rules, reported, rules suspended and referred to the committee on Public Health
- : Referred to the committee on House Rules
Votes
- Committee Vote - Joint Committee on Health Care Financing (July 16, 2026): 13 yea, 0 nay, passed
- Committee Vote - Joint Committee on Public Health (May 22, 2026): 11 yea, 0 nay, passed
Common questions
- What is H5013?
- H5013 is a bill in the Massachusetts Legislature (194th General Court): An Act to establish a celiac disease screening pilot program.
- What is the status of H5013?
- In committee as of July 27, 2026. Latest action: Committee recommended bill ought to pass and referred to the committee on House Ways and Means (July 27, 2026).
- Who sponsored H5013?
- Michelle Badger (D), with 11 co-sponsors.
- Where is the official record for H5013?
- On the Massachusetts Legislature website: https://malegislature.gov/Bills/194/H5013
Source: official Massachusetts record. Tracked by Delilah, AI for legislation across all 50 states and Congress.